Sign in
Active, not recruitingPhase 2

Early Intervention for Premyopic Children

Key facts

Who runs it
National Yang Ming Chiao Tung University Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 2
People taking part
240 people, planned
Started
6 Oct 2024
Ended
Jul 2026
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • MiyoSmart Spectacles
  • 0.01% atropine
Record updated
12 June 2025

Who can take part

Age
5 years to 6 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age at enrollment: 5-6 years old (the senior grade of kindergarten)
  • Cycloplegic SE of the eye with less SE (less positive or more negative refractive error): < +1.00 D and > -0.50 D
  • Astigmatism: 1.0 D or less in both eyes
  • Anisometropia: 1.50 D or less
  • Monocular uncorrected visual acuity: 6/7.5 or better in both eyes
  • Either of the parents with moderate myopia
  • Acceptance of random group allocation
  • Submission of complete informed consent

Who cannot take part

  • Previous treatment of atropine or other myopia control intervention
  • Strabismus or any ocular motility disorder
  • Any ophthalmic and systemic disorders that might affect visual functions or refractive development

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this research project is to add evidence of pharmacological (0.01% atropine) and optical (Defocus Integrated Multiple Segments spectacle lenses) approaches for myopia prevention among premyopic preschoolers, which may contribute to a better understanding of the intervention strategy for myopia control in premyopic children.

The 3 groups in the trial

  • DIMS lensTreatment being tested

    DIMS spectacle lenses. Daily wear for 1.5 years.

    Treatment: MiyoSmart Spectacles

  • 0.01% AtropineTreatment being tested

    0.01% Atropine. One drop per eye, per day, for 1.5 years.

  • Usual careNo study treatment, for comparison

    Usual care including promoting outdoor time

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Intervention for Premyopic Children: A Comparison Study of Defocus Integrated Multiple Segments Spectacle Lenses, 0.01% Atropine and Usual Care for Myopia Prevention
Publications
Record updated
12 June 2025